The Emergency Medicine Pharmacotherapy Literature of 2021

Am J Emerg Med. 2022 Oct:60:88-95. doi: 10.1016/j.ajem.2022.07.039. Epub 2022 Jul 25.

Abstract

This article highlights the most relevant emergency medicine (EM) pharmacotherapy publications indexed in 2021. A modified Delphi approach was utilized for selected journals to identify the most impactful EM pharmacotherapy studies via the GRADE system. After review of journal table of contents GRADE 1A and 1B articles were reviewed by authors. Twenty articles, 2 guidelines, 2 position papers, and 2 meta-analysis were selected for full summary. Articles included in this review highlight acute agitation management, acute appendicitis treatment, sexually transmitted infection updates, optimizing sepsis management and treatment, updates for the ideal thrombolytic agent in acute ischemic stroke and endovascular therapy candidates, indications for tranexamic acid, calicium for out of hospital cardiac arrest, optimial inotrope for cardiogenic shock, awareness during rapid sequence intubation paralysis, comparison of propofol or dexmedetomidine for sedation, treatment of cannabis hyperemsis syndrome, and prophylactic use of diphenhydramine to reduce neuroleptic side effects. Selected articles are summarized to include design, results, limitations, conclusions and impact.

Keywords: Emergency medicine; Pharmacotherapy; Review.

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents*
  • Dexmedetomidine*
  • Diphenhydramine
  • Emergency Medicine*
  • Fibrinolytic Agents
  • Humans
  • Ischemic Stroke*
  • Propofol*
  • Tranexamic Acid*

Substances

  • Antipsychotic Agents
  • Fibrinolytic Agents
  • Dexmedetomidine
  • Tranexamic Acid
  • Diphenhydramine
  • Propofol